Journal
CELL REPORTS
Volume 22, Issue 5, Pages 1250-1262Publisher
CELL PRESS
DOI: 10.1016/j.celrep.2018.01.013
Keywords
-
Categories
Funding
- Cincinnati Children's Hospital Research Foundation
- American Society of Hematology (ASH)
- NIH [R35HL135787, RO1HL111103, RO1DK102759, RO1HL114582]
- Gabrielle's Angel Foundation for Cancer Research
- Edward P. Evans Foundation
- NCI [R35197594, K99 HL122503-01A1]
- MSKCC [P30 CA008748]
- Uehara Memorial Foundation
- Waksman Foundation of Japan
- Mochida Memorial Foundation for Medical and Pharmaceutical Research
- Japan Society for the Promotion of Science
Ask authors/readers for more resources
Basal nuclear factor kappa B (NF-kappa B) activation is required for hematopoietic stem cell (HSC) homeostasis in the absence of inflammation; however, the upstream mediators of basal NF-kappa B signaling are less well understood. Here, we describe TRAF6 as an essential regulator of HSC homeostasis through basal activation of NF-kappa B. Hematopoietic-specific deletion of Traf6 resulted in impaired HSC self-renewal and fitness. Gene expression, RNA splicing, and molecular analyses of Traf6-deficient hematopoietic stem/progenitor cells (HSPCs) revealed changes in adaptive immune signaling, innate immune signaling, and NF-kappa B signaling, indicating that signaling via TRAF6 in the absence of cytokine stimulation and/or infection is required for HSC function. In addition, we established that loss of I kappa B kinase beta (IKK beta)-mediated NF-kappa B activation is responsible for the major hematopoietic defects observed in Traf6-deficient HSPC as deletion of IKK beta similarly resulted in impaired HSC self-renewal and fitness. Taken together, TRAF6 is required for HSC homeostasis by maintaining a minimal threshold level of IKK beta/NF-kappa B signaling.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available